Moore Capital Management, LP Moderna, Inc. Put Options Transaction History

Moore Capital Management, LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $5.73 Million - $11.3 Million	90,000 Added 150.0%	150,000 $10 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $2.86 Million - $3.87 Million	33,500 Added 126.42%	60,000 $6.39 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $243,285 - $365,505	-3,500 Reduced 11.67%	26,500 $2.64 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $2.89 Million - $3.8 Million	30,000 New	30,000 $3.1 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.